Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises in connection with FinnvedenBulten's application to be listed on NASDAQ OMX Stockholm
Mandate

Vinge advises in connection with FinnvedenBulten's application to be listed on NASDAQ OMX Stockholm

May 09, 2011

Vinge advises in connection with FinnvedenBulten's application to be listed on NASDAQ OMX Stockholm and Nordic Capital's offering of shares in connection therewith. Expected start of trading is on May 20, 2011. Handelsbanken Capital Markets and Carnegie Investment Bank are Joint Lead Managers and Joint Book Runners in the offering.

Vinge's project team is composed primarily of Göran Nyström, Pontus Enquist, Dain Nevonen and Christoffer Benninge as well as Lennart Larsson and Lina Hansson regarding tax matters.

Related

Vinge advises HealthCap in conjunction with an investment in Neobiomics

 HealthCap is investing in Neobiomics AB, which develops products in the neonatal field. Neobiomics’ flagship product, Proprems, is a probiotic dietary supplement developed for preterm infants.
May 22, 2026

Vinge advises Sveafastigheter in its merger with KlaraBo

 Vinge advises Sveafastigheter AB (publ) in its merger with KlaraBo Sverige AB.
May 22, 2026

Vinge advises Lagercrantz Group in conjunction with the acquisition of Stalon

 Lagercrantz Group Aktiebolag has acquired 88 per cent of the shares in Stalon AB, a Swedish manufacturer of silencers for hunting firearms. The company is based in Stalon, which is located outside Vilhelmina, where the company conducts development and production in its own facilities.
May 21, 2026